Search the Newsreel

The Manufacturers Life Insurance Company Trims Holdings in Colliers International Group Inc. $CIGI

The Manufacturers Life Insurance Company reduced its stake in Colliers International Group Inc. by 40.3% in the first quarter, selling 319,830 shares and retaining 473,077 shares valued at $50.5 million. Institutional investors hold 80.09% of CIGI, and analysts have a "Moderate Buy" rating with …

Colliers International Group (NASDAQ:CIGI) Issues Quarterly Earnings Results, Beats Expectations By $0.04 EPS

Colliers International Group (NASDAQ:CIGI) announced its second-quarter earnings, reporting $1.83 EPS, surpassing analyst estimates by $0.04. While revenue grew 16.7% year-over-year to $1.38 billion, it fell short of analyst expectations. The company highlighted strong growth in capital markets, leasing, and engineering, and expects leverage …

Scotia Has Lowered Expectations for Colliers International Group (NASDAQ:CIGI) Stock Price

Scotia has lowered its price target for Colliers International Group (CIGI) from $150 to $145, while maintaining a "sector outperform" rating, implying a potential 46.9% upside. Despite several recent target reductions, the stock still holds a "Moderate Buy" consensus rating with an average price …

Colliers International Group (NASDAQ:CIGI) Price Target Raised to $110.00

National Bank Financial has increased its price target for Colliers International Group (NASDAQ:CIGI) to $110.00, maintaining an "outperform" rating, which suggests an 11.44% upside. Despite some analysts lowering targets and one issuing a "sell" rating, the company holds a "Moderate Buy" consensus. Colliers also …

Colliers International Group (NASDAQ:CIGI) Given New $145.00 Price Target at Scotiabank

Scotiabank has lowered its price target for Colliers International Group (NASDAQ:CIGI) to $145 from $150, while maintaining a "sector outperform" rating, projecting a 48.7% upside. Despite this adjustment, the financial services provider surpassed Q2 EPS estimates, reporting $1.83 against a $1.79 consensus, though revenue …

Vanguard Capital Management (COLL) discloses 5.01% passive stake in Collegium

Vanguard Capital Management LLC has disclosed a passive stake of 5.01% in Collegium Pharmaceutical Inc. common stock, totaling 1,625,821 shares, through a Schedule 13G filing. Vanguard holds sole voting power over 244,560 shares and sole dispositive power over all 1,625,821 shares. This filing aggregates …

Colliers International Group Inc. 2026 Q2 - Results - Earnings Call Presentation (TSX:CIGI:CA) 2026-07-31

Colliers International Group Inc. (CIGI:CA) published its Q2 2026 earnings call presentation on July 31, 2026. The company reported an EPS of $2.56, beating estimates by $0.02, and revenue of $2.20 billion, a 17.92% year-over-year increase, beating estimates by $72.63 million. This presentation provides …

Colliers Intl Group Reaffirms Its Outlook for 2026 >CIGI

Colliers International Group has reaffirmed its financial outlook for 2026. The company is maintaining its projections for the upcoming years, indicating confidence in its long-term strategy and market position.

Colliers Inc. - Subordinate Voting Shares Stock 12‑Month Price Target Cut to $138.7, Implies 40% Upside

Colliers International Group Inc (CIGI) Institutional Confidence

This article provides an institutional confidence score for Colliers International Group Inc (CIGI) as of July 30, 2026. It details changes in shareholdings by various institutional investors, including Hennick (Jay Stewart) with a +1.91% change and 1832 Asset Management L.P. with a significant +578.19% …

CollPlant Shareholders Approve Proposal at Extraordinary General Meeting

CollPlant Biotechnologies shareholders approved a single proposal at an Extraordinary General Meeting held in Israel on July 29, 2026, as outlined in an earlier notice. This approval formalizes the company's intended corporate action and ensures adherence to cross-border regulatory requirements through a Form 6-K …

Colliers International Group Inc (CIGI) (Q2 2026) Earnings Call Highlights: Record Revenue and ...

This article first appeared on GuruFocus. Release Date: July 30, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Record quarterly revenue driven by strong performance in investment sales and leasing. Significant growth in …

Collegium Pharmaceutical Inc (COLL) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Collegium Pharmaceutical Inc (COLL), noting its current valuation score of 8.50, which ranks 55 out of 155 in the Pharmaceuticals industry. It highlights the company's P/E ratio of 15.00, comparing it to recent highs and lows. The …

Colliers International Group Inc.

Colliers International Group Inc. (T.CIGI) announced strong financial results for the second quarter ended June 30, 2026. The company reported consolidated revenues of $1.57 billion, up 17%, and net revenues of $1.39 billion, also up 17%. GAAP diluted net earnings per share significantly increased …

Colliers International (CIGI) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

Colliers International (CIGI) reported strong Q2 2026 results, with revenue reaching $1.57 billion and EPS at $1.83, both exceeding analyst expectations. The company saw a 16.7% year-over-year increase in revenue. Key metrics across its Corporate, Commercial Real Estate, Engineering, and Investment Management segments also …

Colliers International Non-GAAP EPS of $1.83 beats by $0.02, revenue of $1.57B beats by $60M

* Colliers International press release [https://seekingalpha.com/filing/309877829] (CIGI [https://seekingalpha.com/symbol/CIGI]): Q2 Non-GAAP EPS of $1.83 beats by $0.02. * Revenue of $1.57B (+16.3% Y/Y) beats by $60M. * 2026 OutlookThe Company reaffirmed its outlook for 2026, which includes the impact of Ayesa. On a consolidated basis, …

[6-K] Colliers International Group Inc. Current Report (Foreign Issuer)

Colliers International Group Inc. reported strong Q2 2026 results with revenues up 17% to $1.57 billion and Adjusted EPS rising 6% to $1.83. The company reaffirmed its 2026 outlook for mid-teens growth in revenues, Adjusted EBITDA, and Adjusted EPS, including the impact of the …

Colliers Reports Second Quarter Results

Colliers International Group Inc Double-digit revenue growth across all three platforms; 2026 outlook reaffirmed Second quarter operating highlights: Three months ended Six months ended June 30 June 30 (in millions of US$, except EPS) 2026 2025 2026 2025 Revenues $ 1,572.5 $ 1,347.6 $ …

Colliers International Group Inc. $CIGI Shares Acquired by Turtle Creek Asset Management Inc.

Turtle Creek Asset Management Inc. significantly increased its stake in Colliers International Group Inc. (NASDAQ:CIGI) by over 100% in the first quarter, now owning 1.63 million shares valued at $174.6 million, representing 3.2% of the company. Despite Colliers missing Q1 earnings and revenue estimates …

CollPlant Biotechnologies (CLGN) investors approve EGM proposal

CollPlant Biotechnologies Ltd. (CLGN) announced that its shareholders approved a proposal at an Extraordinary General Meeting (EGM) held on July 29, 2026. The proposal, detailed in a notice dated July 7, 2026, was approved by the required majority. This report is incorporated by reference …

Colliers Engineering Revenue Reaches $428M, Up 30% in Q2

Collegium Pharmaceutical (COLL) Expected to Post Earnings on Thursday

Colliers International Group (CIGI) Earnings Date and Reports 2026 $CIGI

Colliers International Group (NASDAQ: CIGI) posts 17% Q2 2026 revenue growth

Colliers International (CIGI) Q2 Earnings and Revenues Surpass Estimates

Colliers International (CIGI) came out with quarterly earnings of $1.83 per share, beating the Zacks Consensus Estimate of $1.79 per share. This compares to earnings of $1.72 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an …

Holista Colltech absorbs ProImmune settlement as cash management tightens

Colliers earnings on deck: Can CRE recovery lift results? By Investing.com

Colliers International Group Inc. is set to release its second-quarter earnings, with analysts expecting significant sequential growth in EPS and revenue, testing whether the recovering commercial real estate market is translating into improved financial performance. Investors will be watching transaction volumes, margin performance, and …

Collegium Pharmaceutical Inc (COLL) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Collegium Pharmaceutical Inc (COLL), detailing its volatility, financial risk, and investment risk. The company has a risk assessment score of 7.30, ranking 37 out of 155 in the Pharmaceuticals industry, with a beta of 0.75 indicating underperformance …

ETFs Investing in Colliers International Group Inc. Stocks

This article lists various Exchange Traded Funds (ETFs) that hold Colliers International Group Inc. (CIGI) stocks. The list provides details such as market value, weight, issuer, management style, expense ratio, and AUM for each ETF, aiming to help investors explore opportunities with lower risk. …

Royal Bank of Canada Purchases 129,144 Shares of Colliers International Group Inc. $CIGI

Royal Bank of Canada increased its stake in Colliers International Group Inc. by 3.4% during Q1, purchasing 129,144 additional shares, bringing its total holdings to 3.97 million shares valued at $424.4 million. Despite Colliers International Group missing earnings estimates slightly, analysts generally maintain a …

How Collegium's Quarterly Beat but Softer Outlook Could Reframe Collegium Pharmaceutical (COLL) Investors

Collegium Pharmaceutical reported strong quarterly revenue and earnings that exceeded analyst estimates, but its full-year guidance was softer than expected. This divergence highlights investor focus on how the company's management views its medium-term growth and product momentum, especially given its concentrated portfolio in pain …

Precision Trading with Colliers International Group Inc. (CIGI) Risk Zones

This article provides a detailed AI-driven analysis for Colliers International Group Inc. (CIGI), highlighting a positive near-term sentiment with potential for shifts and a lack of clear price positioning. It presents three distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—tailored to different …

Collective Mining Ltd Revenue Breakdown – TSX:CNL

Collective Mining to List its Shares on the Nasdaq

MIAMI, July 29, 2026 /CNW/ -- Collective Mining Ltd. (NYSE: CNL) (TSX: CNL) ("Collective" or the "Company") is pleased to announce that it will voluntarily transfer its U.S. stock exchange listing from the NYSE American to the Nasdaq Global Select Market® ("Nasdaq"), the highest …

GROV|Grove Collaborative Holdings Inc|Price:1.120|Chg%:+0.030

This article provides a detailed analysis of Grove Collaborative Holdings Inc (GROV) stock, including its current market price, historical performance, key financial figures, and analyst ratings. It highlights the company's stable fundamentals, high growth potential, and "Buy" rating from analysts with a target price …

Collegium Pharmaceutical Inc (COLL) Financial Health: Profitability & Balance Sheet Analysis

Collegium Pharmaceutical Inc (COLL) currently has a financial score of 8.88, ranking 29th out of 155 in the Pharmaceuticals industry, indicating stable financial health and high operating efficiency. The company recently reported a quarterly revenue of $193.52 million, an 8.87% increase year-over-year, alongside a …